ClearPoint Neuro outlines $48M-$52M 2026 revenue guidance as it prioritizes CAL, clinical capacity, and focused ultrasound partnership (NASDAQ:CLPT)
· seekingalpha.com
ClearPoint Neuro (CLPT) Q2 2026 earnings call: guidance cut to $48–$52M, CAL facility ramp, focused ultrasound partnership, and cash burn updates—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...